Satisfaction, Safety and Cost of the Treatment for Multiple Sclerosis Relapse with Intravenous versus Oral Methylprednisolone

Introduction: Relapse is a clinical indication of MS activity. Treatment with corticosteroids is recommended for anti-inflammatory, immunosuppressive effects and reduction in the duration and intensity of symptoms. The dosage of intravenous methylprednisolone (ivMP) is 500-1000 mg daily and that of...

Full description

Bibliographic Details
Main Authors: Montserrat Gonzalez-Platas, Pérez Martín Maria Yaiza, Espinosa Bueno Inmaculada, González Perera Itamar, Díaz Stier Noemi, Eguía del Río Pablo
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2018-10-01
Series:Patient Safety and Quality Improvement Journal
Subjects:
Online Access:http://psj.mums.ac.ir/article_11702_d41d8cd98f00b204e9800998ecf8427e.pdf